These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 14734482

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Rapamycin is an effective inhibitor of human renal cancer metastasis.
    Luan FL, Ding R, Sharma VK, Chon WJ, Lagman M, Suthanthiran M.
    Kidney Int; 2003 Mar; 63(3):917-26. PubMed ID: 12631072
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy.
    Luan FL, Hojo M, Maluccio M, Yamaji K, Suthanthiran M.
    Transplantation; 2002 May 27; 73(10):1565-72. PubMed ID: 12042641
    [Abstract] [Full Text] [Related]

  • 6. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
    Rupertus K, Dahlem C, Menger MD, Schilling MK, Kollmar O.
    Ann Surg Oncol; 2009 Sep 27; 16(9):2629-37. PubMed ID: 19551445
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sirolimus (rapamycin) potentiates cyclosporine in prevention of acute lung rejection.
    Longoria J, Roberts RF, Marboe CC, Stouch BC, Starnes VA, Barr ML.
    J Thorac Cardiovasc Surg; 1999 Apr 27; 117(4):714-8. PubMed ID: 10096966
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Japonicone A inhibits the growth of non-small cell lung cancer cells via mitochondria-mediated pathways.
    Du Y, Gong J, Tian X, Yan X, Guo T, Huang M, Zhang B, Hu X, Liu H, Wang Y, Li J, Li M.
    Tumour Biol; 2015 Sep 27; 36(10):7473-82. PubMed ID: 25908173
    [Abstract] [Full Text] [Related]

  • 13. Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non-human primates: trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickening.
    Ikonen TS, Gummert JF, Serkova N, Hayase M, Honda Y, Kobayase Y, Hausen B, Yock PG, Christians U, Morris RE.
    Transpl Int; 2000 Sep 27; 13 Suppl 1():S314-20. PubMed ID: 11112022
    [Abstract] [Full Text] [Related]

  • 14. Possible mechanism by which rapamycin increases cyclosporine nephrotoxicity.
    Cheng CH, Chang HR, Chiang CW, Shu KH, Chou MC.
    Transplant Proc; 2008 Sep 27; 40(7):2373-5. PubMed ID: 18790238
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiproliferative effect of human interleukin-4 in human cancer cell lines: studies on the mechanism.
    Topp MS, Papadimitriou CA, Eitelbach F, Oelmann E, Koehler B, Oberberg D, Von Marschall Z, Reufi B, Stein H, Thiel E.
    Leuk Lymphoma; 1995 Oct 27; 19(3-4):319-28. PubMed ID: 8535226
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Consumption of S-allylcysteine inhibits the growth of human non-small-cell lung carcinoma in a mouse xenograft model.
    Tang FY, Chiang EP, Pai MH.
    J Agric Food Chem; 2010 Oct 27; 58(20):11156-64. PubMed ID: 20866043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.